Cargando…

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer()

BACKGROUND: IGFBP-3 is a multifunctional protein that inhibits growth and induces apoptosis of cancer cells. Hypermethylation of the promoter represses expression of the IGFBP-3 gene. We undertook this study to assess the impact of IGFBP-3 methylation on survival of early stage gastric cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seung Tae, Jang, Hye-Lim, Lee, Jeeyun, Park, Se Hoon, Park, Young Suk, Lim, Ho Yeong, Choi, Min Gew, Bae, Jae Moon, Sohn, Tae Sung, Noh, Jae Hyung, Kim, Sung, Kim, Kyoung-Mee, Kang, Won Ki, Park, Joon Oh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562974/ https://www.ncbi.nlm.nih.gov/pubmed/26310375 http://dx.doi.org/10.1016/j.tranon.2015.06.001

Ejemplares similares

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2018)

The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2016)

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability
por: Cho, Junhun, et al.
Publicado: (2017)

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
por: Yu, Jeong Il, et al.
Publicado: (2020)

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
por: Yu, Jeong Il, et al.
Publicado: (2019)

The Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
por: Kim, Se Yeong, et al.
Publicado: (2012)

Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
por: Lee, Jeeyun, et al.
Publicado: (2014)

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
por: Lim, Do Hyoung, et al.
Publicado: (2010)

A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
por: Lee, Jeeyun, et al.
Publicado: (2013)

Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach Cancer
por: Park, Jun Su, et al.
Publicado: (2022)

Deep Learning–Based Survival Analysis Identified Associations Between Molecular Subtype and Optimal Adjuvant Treatment of Patients With Gastric Cancer
por: Lee, Jeeyun, et al.
Publicado: (2018)

Early gastric cancer arising from heterotopic gastric mucosa in the gastric submucosa
por: Kim, Dae Hoon, et al.
Publicado: (2011)

Adenocarcinoma derived from gastric hamartomatous polyps
por: Oh, Seung Jong, et al.
Publicado: (2011)

A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer
por: An, Ji Yeong, et al.
Publicado: (2020)

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017)

Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer
por: Kang, Guhyun, et al.
Publicado: (2013)

Prognostic significance of suprapancreatic lymph nodes and its implication on D2 dissection
por: Ha, Man Ho, et al.
Publicado: (2018)

Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses
por: Park, Jun Su, et al.
Publicado: (2020)

Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy
por: Kim, Seung Tae, et al.
Publicado: (2017)

Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
por: Hong, Jung Yong, et al.
Publicado: (2020)

High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer
por: Kim, Seokhwi, et al.
Publicado: (2014)

Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
por: Kim, Su Mi, et al.
Publicado: (2018)

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Radiofrequency Ablation for Hepatic Metastasis from Gastric Adenocarcinoma
por: An, Ji Yeong, et al.
Publicado: (2008)

Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case
por: Kim, Su Mi, et al.
Publicado: (2017)

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors
por: Kim, Hana, et al.
Publicado: (2021)

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2014)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia
por: Oh, Sung Eun, et al.
Publicado: (2023)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial
por: Lim, Sung Won, et al.
Publicado: (2018)

To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients
por: Lee, Hansang, et al.
Publicado: (2016)

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
por: LIM, SUNG HEE, et al.
Publicado: (2023)

Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy
por: Ryu, Kyeong-Won, et al.
Publicado: (2021)

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)
por: Heo, Mi Hwa, et al.
Publicado: (2017)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)

A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer
por: Kim, You Na, et al.
Publicado: (2019)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bd6t106gs0cmantt4eah81k140